FDA Clears Sentient’s Tixel for Treatment of Periorbital Wrinkles
Sentient announces that the U.S. Food and Drug Administration has approved Tixel by Sentient, its non-invasive skin resurfacing technology, for the treatment of periorbital wrinkles.
Sentient announces that the U.S. Food and Drug Administration has approved Tixel by Sentient, its non-invasive skin resurfacing technology, for the treatment of periorbital wrinkles.
The collagen-based dermal regeneration template is designed for improved patient outcomes in the treatment of full-thickness wounds.